{
    "nctId": "NCT06127979",
    "briefTitle": "A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery",
    "officialTitle": "Differential Changes in Ki67 Between Carriers and Noncarriers of BRCA2 Mutations With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-negative Breast Cancer Treated With Preoperative Endocrine Therapy",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 42,
    "primaryOutcomeMeasure": "assess the change in Ki67",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Postmenopausal women aged \u226518 years with biopsy-proven stage I-III invasive breast cancer that is ER+/HER2-\n* Scheduled to undergo upfront surgery\n* Eligible for genetic testing in accordance with National Comprehensive Cancer Network guidelines\n\nExclusion Criteria:\n\n* History of breast cancer\n* Receipt of ET for risk reduction in the previous 3 months\n* Stage IV disease at presentation\n* Scheduled to undergo neoadjuvant systemic chemotherapy\n* Pregnant",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}